CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 22 enrolled
Drug / intervention
Vancomycindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02020031
NCT02020031Phase 3Completed
CompareCT.gov

Regional Prophylactic Vancomycin in Revision Total Knee Replacement

Mayo Clinic·interventional·Posted Dec 24, 2013·Updated Nov 25, 2016

In Brief

A Phase 3 clinical trial evaluating Vancomycin for Arthropathy of Knee Joint. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (the knee joint) is more effective at preventing infection than the current standard dose which is given intravenously (IV) through a wrist vein.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthropathy of Knee Joint
CountriesUnited States
CollaboratorsVidacare Corporation

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 24, 2013
Enrollment StartDec 1, 2013
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.5 years ago

Interventions

Vancomycindrug